SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-41026"
 

Search: onr:"swepub:oai:DiVA.org:umu-41026" > Hyperferritinemia i...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Wahlin, AndersUmeå universitet,Onkologi,Department of Hematology, Cancer Centre, University Hospital, 90185 Umea, Sweden (author)

Hyperferritinemia is associated with low incidence of graft versus host disease, high relapse rate, and impaired survival in patients with blood disorders receiving allogeneic hematopoietic stem cell grafts.

  • Article/chapterEnglish2011

Publisher, publication year, extent ...

  • 2010-04-15
  • Springer Science and Business Media LLC,2011
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:umu-41026
  • https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-41026URI
  • https://doi.org/10.1007/s12032-010-9496-1DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-233808URI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:122702595URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • High pre-transplantation serum ferritin levels have been reported to be associated with impaired survival post-transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome. We performed a retrospective study of 309 patients who underwent allogeneic hematopoietic stem cell transplantation at two transplantation centers. The aim was to determine the effect of pre-transplantation hyperferritinemia on survival, graft versus host disease, and relapse. In both univariate and multivariate analysis, elevated ferritin levels were significantly associated with shorter overall and relapse-free survival times and increased relapse rate, but lower risk of chronic graft versus host disease. Elevated ferritin levels were not associated with non-relapse mortality. We hypothesize that ferritin may exert an immunosuppressive effect, reducing graft versus host disease and graft versus leukemia effects, resulting in increased risk of relapse and impaired survival.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lorenz, FryderykUmeå universitet,Onkologi,Hematology, Department of Radiation Sciences(Swepub:umu)frlo0008 (author)
  • Fredriksson, MarithaDepartment of Hematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (author)
  • Remberger, MatsKarolinska Institutet (author)
  • Wahlin, Björn EKarolinska Institutet (author)
  • Hägglund, HansDepartment of Hematology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden (author)
  • Umeå universitetOnkologi (creator_code:org_t)

Related titles

  • In:Medical Oncology: Springer Science and Business Media LLC28:2, s. 552-5581357-05601559-131X

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view